Clinical spectrum of impulse control disorders in Parkinson’s disease

Cited by (311)

Items 201–300 of 311

  1. Clinical practice guidelines based on evidence for cognitive‐behavioural therapy in Parkinson's disease comorbidities: A literature review
    Ivan Zečević · 2020 · Clinical Psychology & Psychotherapy
  2. Interconnected desires: A systematic review of compulsive buying-shopping disorder and its links to disordered eating and body image by gender
    Nora M. Laskowski, Cristina Ballero Reque, Pauline Reiß, Marie Pahlenkemper, Gerrit Brandt, Georgios Paslakis · 2025 · Journal of Behavioral Addictions
  3. Neural network localization in Parkinson’s disease with impulse control disorders
    Hucheng Yang, Siyu Gu, Hai-Hua Sun, Feng Zhang, Zhenyu Dai, Pinglei Pan · 2025 · Frontiers in Aging Neuroscience
  4. Addressing sexuality and intimacy in people living with Parkinson's during palliative care and at the end of life
    Jenny Wright · 2019 · British Journal of Nursing
  5. Phenomenology and gender characteristics of hobbyism and punding in Parkinson’s disease: A self-report study
    Mette Buhl Callesen, Malene Flensborg Damholdt · 2017 · Basal Ganglia
  6. A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson’s Disease
    Anne Sauvaget, Susana Jiménez‐Múrcia, Fernando Fernández‐Aranda, Roser Granero, Marie Grall‐Bronnec, Caroline Victorri‐Vigneau, Samuel Bulteau, Pascal Derkinderen, Jean M. Vanelle, Anders Håkansson et al. · 2017 · Frontiers in Psychiatry
  7. Persisting or Worsening Impulse Control Disorders in Parkinson's Disease Following a Switch to Subcutaneous Foslevodopa‐Foscarbidopa
    Maeve Bradley, Eoghan Donlon, Amy Gallagher, Federica Ruggieri, John Inocentes, Antonio Diaz Rua, Clodagh O’Keeffe, T. H. Lynch, Conor Fearon, Richard A. Walsh · 2026 · Movement Disorders Clinical Practice
  8. Progress of non‐motor symptoms in early‐onset Parkinson's disease
    Fanshi Zhang, Ai‐Di Luo, Shusheng Liao, Mei Liu, Jun Zhang, Zucai Xu · 2024 · Ibrain
  9. Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease
    Sara C. Staubo, Ole‐Martin Fuskevåg, Mathias Toft, Ingeborg Haugesag Lie, Kirsti M. J. Alvik, Pål Jostad, Stein H. Tingvoll, Hallvard Lilleng, Kristina Rosqvist, Elisabet Størset et al. · 2025 · Journal of Neurology
  10. EEG changes induced by dopamine replacement therapy in Parkinson’s disease with impulse control disorders
    Juan Francisco Martin‐Rodríguez, Elena Iglesias Camacho, Francisco Javier Gómez-Campos, Pablo Franco‐Rosado, Lorena Garrote-Espina, Laura Muñoz‐Delgado, Silvia Jesús, Daniel Macías‐García, Astrid Daniela Adarmes-Gómez, Fátima Carrillo et al. · 2025 · Clinical Neurophysiology
  11. Dopamine-Related Reduction of Semantic Spreading Activation in Patients With Parkinson’s Disease
    Hannes Ole Tiedt, Felicitas Ehlen, Fabian Klostermann · 2022 · Frontiers in Human Neuroscience
  12. Dopaminergic medication improves cognitive control under low cognitive demand in Parkinson’s disease.
    Isobel Anne Williams, Ignacio Obeso, Marjan Jahanshahi · 2020 · Neuropsychology
  13. Impulse Control Disorders in Parkinson’s Disease and Atypical Parkinsonian Syndromes—Is There a Difference?
    Mateusz Toś, Anna Grażyńska, Sofija Antoniuk, Joanna S. Siuda · 2024 · Brain Sciences
  14. The changing tree in Parkinson's disease
    Paolo Calabresi, Massimiliano Di Filippo · 2015 · Nature Neuroscience
  15. Positron emission tomography in Parkinson’s disease: insights into impulsivity
    Adam J. Stark, Daniel O. Claassen · 2017 · International Review of Psychiatry
  16. Comparing the impact of low frequency vs high frequency deep brain stimulation in Patient’s with Parkinson’s disease: A systematic review
    Govind Singh Mann, Binay Kumar Panjiyar, MD Parbej Allam, Fnu Asifa, Ahsan Ullah, Shivangi Jha · 2025 · Brain Disorders
  17. Atypical Psychosis in Parkinson Disease
    Lindun Ge, Yasuyoshi Kimura, Keita Kakuda, Kotaro Ogawa, Yuta Kajiyama, Kanako Asai, Seira Taniguchi, Goichi Beck, Yoshiyuki Nishio, Jee Hyun Kim et al. · 2025 · Neurology Clinical Practice
  18. Improvement of apathy in early Parkinson’s disease
    A. Castrioto, E. Schmitt, M. Anheim, S. Meoni, H. Klinger, D. Sourd, P. Pelissier, E. Lhommée, A. Bichon, C. Tranchant et al. · 2025 · npj Parkinson's Disease
  19. Capacity, control and responsibility in Parkinson’s disease patients with impulse control disorders: Views of neurological and psychiatric experts
    Andrew Dawson, Jordie Michael, Ella Dilkes‐Frayne, Wayne Hall, Nadeeka N. Dissanayaka, Adrian Carter · 2018 · International Journal of Law and Psychiatry
  20. Evaluación de síntomas no motores y descontrol de impulsos en usuarios con enfermedad de Parkinson por el médico en atención primaria
    Philippe Salles Gándara, Pedro Chaná‐Cuevas · 2020 · Revista médica de Chile
  21. Cognitive Behavioral Therapy Plus a Serious Game as a Complementary Tool for a Patient With Parkinson Disease and Impulse Control Disorder: Case Report
    Teresa Mena-Moreno, Lucero Munguía, Roser Granero, Ignacio Lucas, Almudena Sánchez‐Gómez, Ana Cámara, Yaroslau Compta, Francesc Valldeoriola, Fernando Fernández‐Aranda, Anne Sauvaget et al. · 2022 · JMIR Serious Games
  22. Gaze‐speech coordination during social interaction in Parkinson's disease
    Timothy L. Hodgson, Frouke Hermens, Gemma Ezard · 2023 · International Journal of Language & Communication Disorders
  23. Emission of 50-kHz ultrasonic vocalizations stimulated by antiparkinsonian dopaminomimetic drugs in hemiparkinsonian rats is associated with neuronal activation in subcortical regions that regulate the affective state
    Marcello Serra, Jacopo Marongiu, Nicola Simola, Giulia Costa · 2024 · Experimental Neurology
  24. Validation of the Chinese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease
    Tian Xu, Lanxiao Cao, Wenying Long, Guohua Zhao · 2021 · Frontiers in Neurology
  25. Assessment of Repetitive and Compulsive Behaviors Induced by Pramipexole in Rats: Effect of Alpha-Synuclein-Induced Nigrostriatal Degeneration
    Mélina Decourt, Éric Balado, Haritz Jiménez‐Urbieta, Maureen Francheteau, Pierre‐Olivier Fernagut, Marianne Benoit‐Marand · 2022 · Biomedicines
  26. Development and Validation of a Daily Habit Scale
    Dejan Georgiev, Rosie Christie, Mariam Torkamani, Ruifeng Song, Patricia Dowsey Limousin, Marjan Jahanshahi · 2022 · Frontiers in Neuroscience
  27. Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?
    Odette Fründt, Mazen Fadhel, Christoph Heesen, Susan Seddiq Zai, Christian P Gerloff, Eik Vettorazzi, Jana Pöttgen, Carsten Buhmann · 2022 · Journal of Parkinson s Disease
  28. Recurrent Impulse Control Disorder Associated with Rasagiline Treatment of Parkinson’s Disease
    Ariel Levy, Anthony Edward Lang · 2016 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  29. Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism
    Jun-Ping Liu, Jian-Feng Li, Yanhua Lu, Li-Hui Wang, Gang Chen · 2017 · Clinical and Experimental Pharmacology and Physiology
  30. Abnormal subcortical volumes and cortical thickness in Parkinson's disease with impulse control disorders
    Pramod Kumar Pal, Shweta Prasad, Venkateswara Reddy Reddam, Albert Stezin, Ravi Yadav, Jitender S. Saini · 2018 · Annals of Indian Academy of Neurology
  31. Serotonergic cortico-limbic and executive network dysfunction in Parkinson’s disease impulse control disorders: a PET-fMRI study
    Damiano Terenzi, Élise Météreau, Franck Lamberton, Hélène Klinger, Marine Huddlestone, Melinda De Oliveira, Jérôme Redouté, Léon Tremblay, Stéphane Thobois, Stéphane Prange · 2026 · npj Parkinson s Disease
  32. Neuropsychological aspects of impulse control disorders in Parkinson’s disease
    Livia Scanferla, Atbin Djamshidian · 2026 · Frontiers in Aging Neuroscience
  33. Similarities and Differences Between “Old” and “New” Addictions: The Focus on Executive Functions and Reward Mechanisms
    Michela Balconi · 2021 · Advances in mental health and addiction
  34. A systematic review of the factors associated with the psychological wellbeing of people with Parkinson’s in the COVID-19 pandemic
    H. Gotheridge, Fiona Juliet Rosalind Eccles, Craig D. Murray, R. Henderson, Jane Simpson · 2024 · Disability and Rehabilitation
  35. Devotion to painting in a Parkinson’s disease patient
    Nozomu Matsuda, Shunsuke Kobayashi, Yoshikazu Ugawa · 2018 · Rinsho Shinkeigaku
  36. The Clinical Neuropsychiatry of “Organic” Obsessive-Compulsive Disorder
    Leonardo Franklin Fontenelle · 2018 · Cambridge University Press eBooks
  37. Accentuated Paralimbic and Reduced Mesolimbic D2/3-Impulsivity Associations in Parkinson's Disease
    Adam J. Stark, Alexander K. Song, Kalen J. Petersen, Kaitlyn R. Hay, Ya‐Chen Lin, Paula Trujillo, Hakmook Kang, Jenna M. Collazzo, Manus Joseph Donahue, David Harold Zald et al. · 2023 · Journal of Neuroscience
  38. Impulse control and related behavioral disorders in Parkinson’s disease. Risk factors, diagnosis, and management. Is there a possible role for non-invasive brain stimulation?
    Stefano Terruzzi, Lina Urh, D. Piscitelli, M. Rosanova, Cecilia Perin · 2025 · Neurological Sciences
  39. Incapacity of the Mind Secondary to Medication Misuse as a Not Criminally Responsible Defense
    Sebastien S Prat, Bruno J. Losier, Heather Marie Moulden, Gary Andrew Chaimowitz · 2016 · Journal of Forensic Sciences
  40. A clinical and genetic study of impulsive-compulsive disorders in patients with Parkinson's disease
    N N Shipilova, Nataliya Titova, Кокаева Зарема Григорьевна, Anna Fedosova, Е.А. Климов, Е А Катунина · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  41. Mania triggered by levodopa treatment in a patient with frontotemporal dementia caused by A C9orf72 repeat expansion: A case report
    Gorm Thorlacius-Ussing, Jørgen Erik Nielsen, Ian G. Law, Hanne Vibe Hansen, Andersen Birgitte Bo · 2020 · Clinical Neurology and Neurosurgery
  42. Tattooing as a Symptom of Impulse Control Disorder in a Parkinsonian Patient With Pramipexole
    David Maltête, Floriane Le Goff, Gülden Özel, Romain Lefaucheur · 2016 · Journal of Clinical Psychopharmacology
  43. APOE contributes to longitudinal impulse control disorders progression in Parkinson’s disease
    Linxi Chen, Xinwei He, Lingqun Mao, Peng Liu · 2024 · BMC Psychiatry
  44. Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2/3 agonist and L-DOPA treatment
    Mirjam Wolfschlag, Elena Espa, Katrine Skovgård, Pär Halje, Maria Angela Cenci · 2025 · npj Parkinson s Disease
  45. Parkinson’s Disease: Pathophysiology, Treatment Strategies, Wellness Approaches, and Obstacles/Paths Forward
    Frank Church, Jill C. Rau, Stefania Brotini · 2026 · NeuroSci
  46. Guidelines for Therapeutic Management of Parkinson’s Disease in China
    Lin Lü, Shengdi Chen, Yuting Yang, Yangfu Luo, Pingyi Xu, Weidong Le · 2021 · Springer eBooks
  47. Subjective feelings associated with expectations and rewards during risky decision-making in impulse control disorder
    Brittany Liebenow, Angela Jiang, Emily K. DiMarco, L. Paul Sands, Mary E. Moya‐Mendez, Adrian W. Laxton, Mustafa Siddiqui, Ihtsham ul Haq, Kenneth T. Kishida · 2024 · Scientific Reports
  48. Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression
    Holly Spencer, Ryan S. Anderton · 2024 · Parkinson s Disease
  49. Challenges and Frontiers in Computational Metabolic Psychiatry
    Anthony G. Chesebro, Botond B. Antal, Corey Weistuch, Lilianne Rivka Mujica-Parodi · 2024 · Biological Psychiatry Cognitive Neuroscience and Neuroimaging
  50. Pharmacotherapy for Behavioral Addictions
    Jon Edgar Grant, Samuel Robin Chamberlain · 2016 · Current Behavioral Neuroscience Reports
  51. The Implications of Parkinson's Disease for Women's Health
    Ingrid Pretzer‐Aboff, Lisette K. Bunting-Perry, Meredith Spindler · 2016 · Journal of Obstetric, Gynecologic & Neonatal Nursing
  52. Neuropsychological Aspects: Impulse-Control Disorders and Other Neuropsychiatric Features in RBD
    Maria Livia Fantini, Franck Durif, Ana Marquès · 2018 · Springer eBooks
  53. Streamlining the management of Parkinson disease in Canada
    Veronica Andrea Bruno, Maria Eliza Freitas · 2019 · Canadian Medical Association Journal
  54. The mediating effects of depression, anxiety, and rapid eye movement sleep behavior disorder on the association between dopaminergic replacement therapy and impulse control disorders in Parkinson’s disease
    Sidan Du, Ying Huang, Yifei Ma, Yao Qin, Jing Cui, Wenlin Bai, Hongjuan Han, Rong Zhang, Hongmei Yu · 2022 · Neurological Sciences
  55. L’hypophyse et ses traitements : comment peuvent-ils influer sur le comportement ?
    Céline Mouly, Françoise Borson‐Chazot, Philippe Jean Caron · 2017 · Annales d Endocrinologie
  56. fMRI in Parkinson’s Disease
    Hartwig Roman Siebner, David Meder, Damian Marc Herz · 2020 · Springer eBooks
  57. Is GBA1 mutation status a game-changer for impulse control behaviour in Parkinson's disease?
    Nikola D. Kresojević, Vladana Marković, Cveta Geratović, Milica Ječmenica‐Lukić, Aleksandra Tomić, Valerija Dobričić, Iva Stanković, Tanja Stojković, Nataša Dragašević, Maksim Šarčević et al. · 2025 · Neurological Sciences
  58. Involuntary Movement Disorders
    David Myland Kaufman, Howard L. Geyer, Mark J. Milstein · 2017 · Elsevier eBooks
  59. Drugs That Affect Autonomic Functions or the Extrapyramidal System
    Toshio Nakaki · 2016 · Side effects of drugs annual
  60. Treatment of Dopamine Dysregulation Syndrome and Impulse Control Disorders in Parkinson’s Disease
    Mark A. Stacy · 2019 · Current clinical neurology
  61. Treatment of Impulse Control Disorders and Dopamine Agonist Withdrawal Syndrome in Parkinson’s Disease
    Melissa Jill Nirenberg · 2019 · Current clinical neurology
  62. The Agony of the Agonists: a Review of Impulsivity and Withdrawal Syndromes in Parkinson's Disease Treatment
    Andrea J Lindahl, Douglas G MacMahon · 2015 · Future Neurology
  63. Impact of Comorbid Autism Spectrum Disorder in an Individual with Idiopathic Young-Onset Parkinson’s Disease
    Martijne Oudkerk, Rianne A.J. Esselink, Cees C Kan, Indira Tendolkar, Marleen H.C.T. Van Beek · 2018 · Advances in Neurodevelopmental Disorders
  64. Trastornos de control de impulsos: adicciones conductuales en la enfermedad de Parkinson
    Luis Enrique Parra-Medina, José Luis Góngora-Alfaro · 2020 · eNeurobiología
  65. Impulsive and compulsive parkin disease
    Timothy Lynch, Shinsuke Fujioka · 2016 · Neurology
  66. Impact of Deep Brain Stimulation on Addictive Behaviors: A Case Series of Parkinsonian Patients
    I. de Chazeron, Céline Lambert, Jean‐Luc Houéto, Georges Brousse, Nématollah Jaafari, Olivier Rascol, Fabienne Ory‐Magne, Paul Krack, G Barroche, Raymund Schwan et al. · 2024 · Preprints.org
  67. La dysrégulation hédoniste comme forme d’anosognosie dans la maladie de Parkinson ?
    Marie‐Andrée Bruneau · 2016 · NPG. Neurologie, psychiatrie, gériatrie/NPG
  68. Neue Medikamente zur Behandlung des idiopathischen Parkinson-Syndroms
    Heinz Reichmann · 2016 · InFo Neurologie + Psychiatrie
  69. Drugs that affect autonomic functions or the extrapyramidal system
    Toshio Nakaki · 2014 · Side effects of drugs annual
  70. Medication Side Effect Profiles in PD Patients in a Safety-Net Hospital
    Daniella C. Sisniega, Divya K. Madhusudhan, Elham Rahmani, Robert P. McInnis, Janice Weinberg, Marie Saint‐Hilaire, Anna DePold Hohler · 2017 · Advances in Parkinson s Disease
  71. Impulsivity in Patients with Parkinson’s Disease
    Rumyana N. Kuzmanova, Irina Stefanova, Katerina I. Stambolieva · 2017 · Journal of Biomedical and Clinical Research
  72. Improving the management of Parkinson's disease : the experience of hospitalisation and a novel MRI-based diagnostic tool
    Sharon Muzerengi · 2017 · University of Birmingham Institutional Research Archive (University of Birmingham)
  73. Quantifying the subjective experience of initiating and monitoring actions, in health and disease
    Steven Di Costa · 2017 · UCL Discovery (University College London)
  74. Indications for Deep Brain Stimulation Therapy in Parkinson’s Disease
    Andrea Archambault Brock, Melissa Hardy, Paul A. House · 2018 · Springer eBooks
  75. Parkinson’s Disease
    Banu Cahide Tel, Gül Yalçın Çakmaklı · 2017 · Elsevier eBooks
  76. The Christmas gathering: a household guide to neurological symptoms. How to use the most versatile and common object patients use, a home, in neurological diagnostics
    Maja Klarendić, Maja Kojović · 2018 · Postgraduate Medical Journal
  77. NEUROPSYCHOLOGICAL CORRELATES OF STRIATAL DOPAMINERGIC DYSFUNCTION IN PARKINSON’S DISEASE
    Brittany D. Walls · 2020 · UKnowledge (University of Kentucky)
  78. Affective and personality disorders in Parkinson's disease premotor phase. Pilot study.
    Marina A. Samushiya, A. A. Ragimova, Смоленцева Ирина Геннадьевна, Maksimenko M.Yu., E.I. Ivannikova · 2020 · Cognitive Remediation Journal
  79. Impulse Control and Related Disorders in Parkinson's Disease: Special Issues and Implications
    Gregory M. Pontone, Howard D. Weiss · 2020 · Psychiatric Annals
  80. Objective Assessment of Impulse Control Disorder in Patients with Parkinson’s Disease Using a Low-Cost LEGO-Like EEG Headset
    Yuan‐Pin Lin, Hsing-Yi Liang, Yueh-Sheng Chen, Cheng‐Hsien Lu, Yih‐Ru Wu, Yung‐Yee Chang, Wei‐Che Lin · 2020 · Research Square
  81. I Don’t Know When to Stop
    Keith A. Josephs, Federico E Rodriguez‐Porcel, Rhonna S. Shatz, Daniel A. Weintraub, Alberto Javier Espay · 2020 · Cambridge University Press eBooks
  82. Morbus Parkinson und Neuropsychologie
    Claus‐W. Wallesch · 2021 · Fortschritte der Neurologie · Psychiatrie
  83. Multidimensional clustering with Bayesian networks
    Fernando Rodríguez Sánchez · 2021
  84. Neuropsychiatrische symptomen bij de ziekte van Parkinson: een gevalsbeschrijving
    L. De Ketelaere, Filip Van Den Eede, Ségolène De Waele, Ilse De Volder, David Crosiers · 2022 · Tijdschrift voor Geneeskunde
  85. fMRI in Parkinson’s Disease
    Hartwig Roman Siebner, Damian Marc Herz · 2013 · Springer eBooks
  86. Guidelines for Therapeutic Management of Parkinson’s Disease in China
    Lin Lü, Shengdi Chen, Yuting Yang, Yangfu Luo, Pingyi Xu, Weidong Le · 2022 · Springer eBooks
  87. D1R-PKA signaling activation in PFC mediated by GDNF facilitates depression remission in Parkinson's disease
    Yehao Liu, Xiaoyu Zhou, Ke Xue, Ruiao Sun, Yan Tang, Chuanxi Tang · 2023 · Research Square
  88. Daily Habits in Parkinson's Disease: Validation of the Daily Habit Scale
    Dejan Georgiev, Asma Torkmani, Ruifeng Song, Patricia Dowsey Limousin, Marjan Jahanshahi · 2023 · Movement Disorders Clinical Practice
  89. Acute psychiatric problems in movement disorders
    Daniele Urso, Veria Vacchiano, Giovanni Rizzo, Giancarlo Logroscino · 2023 · International review of movement disorders
  90. Sub-second Dopamine Signals during Risky Decision-Making in Patients with Impulse Control Disorder
    Brittany Liebenow, Thomas Wilson, Benjamin Maas, Emily Aladnani, Rosalyn Moran, Jason P. White, Terry M. Lohrenz, Ihtsham ul Haq, Mustafa Siddiqui, Adrian W. Laxton et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Different impulse control disorder evolution patterns and white matter microstructural damage in the progression of Parkinson’s disease
    Ling Hu, Changfu Lin, Fabin Lin, Lingling Wang, Zhenzhen Li, Zhijun Cai, Xianghong Liu, Qinyong Ye, Yiwen Wu, Guoen Cai · 2023 · Frontiers in Aging Neuroscience
  92. Autres troubles neurologiques et addictions
    Maurice Demattéis, Lucie Pennel · 2023 · Elsevier eBooks
  93. Othello syndrome and dopamine dysregulation syndrome
    Rim Masmoudi, Emna Derbel, Farah Cherif, Salma Hentati, Inès Féki, Rim Sellami, Jawaher Masmoudi · 2024 · Progress in Neurology and Psychiatry
  94. A ação dos fármacos para o tratamento na Doença de Parkinson e as possíveis alterações no comportamento alimentar: uma Revisão Integrativa
    Fábio Antônio Mota Fonseca da Silva, Débora Carla Monteiro de Oliveira, Kayane Victoria Barreto Bernardino, Lyvia Maria De Almeida Melo, Amanda de Hollanda Winkler, Camilla de Andrade Tenório Cavalcanti, Sara Maria Xavier da Cruz, Vanessa Ribeiro Leite Celestino, Isvânia Maria Serafim da Silva Lopes · 2024 · Inova Saúde
  95. Examining the presence and frequency of impulse control disorders in Wilson's disease
    Ana Nikolić, Danilo Mladenović, Vladana Marković · 2024 · Medicinski podmladak
  96. Early Onset Parkinson’s Disease and Sleep Dysfunction
    Shweta Prasad, Rosabel Chen, Pramod Kumar Pal · 2025 · Sleep Medicine Clinics
  97. Apathy and impulsivity in neurological and psychiatric disorders
    Youssuf Saleh, Masud Husain · 2025 · Handbook of behavioral neuroscience
  98. Predictors of Impulse Control Disorders in Patients with Parkinson’s Disease
    Mohammed Farhan Ansari, Nitish L. Kamble, Vikram Venkappayya Holla, Ravi Yadav, Rohan Ramachandra Mahale, Pramod Kumar Pal · 2025 · Annals of Indian Academy of Neurology
  99. Alterations in cortical sulcal morphology in Parkinson’s disease patients with impulse control disorders
    Qianqian Si, Jiaxin Shi, Xingyue Cao, Caiting Gan, Shiyang Yu, Huimin Sun, Xufeng Wang, Xinping Wang, Guanqun Wang, Kezhong Zhang et al. · 2025 · Neuroscience
  100. Maladie de Parkinson et trouble du contrôle des impulsions
    K. Rousvoal, J.-C. Corvol · 2026 · Encyclopédie médico-chirurgicale. Neurologie